Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv in adolescents with ADHD
NCT01081132Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Sep 2011; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01081132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081132.